Connor, Clark & Lunn Investment Management (CC&L)’s AtriCure ATRC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.66M | Buy |
264,344
+40,775
| +18% | +$1.34M | 0.03% | 432 |
|
|
2025
Q1 | $7.21M | Buy |
223,569
+41,847
| +23% | +$1.35M | 0.03% | 401 |
|
|
2024
Q4 | $5.55M | Sell |
181,722
-4,097
| -2% | -$125K | 0.03% | 457 |
|
|
2024
Q3 | $5.21M | Buy |
185,819
+52,533
| +39% | +$1.47M | 0.03% | 421 |
|
|
2024
Q2 | $3.03M | Buy |
133,286
+56,380
| +73% | +$1.28M | 0.01% | 546 |
|
|
2024
Q1 | $2.34M | Buy |
76,906
+40,559
| +112% | +$1.23M | 0.01% | 626 |
|
|
2023
Q4 | $1.3M | Buy |
36,347
+16,259
| +81% | +$580K | 0.01% | 782 |
|
|
2023
Q3 | $880K | Sell |
20,088
-39,560
| -66% | -$1.73M | ﹤0.01% | 857 |
|
|
2023
Q2 | $2.94M | Buy |
59,648
+16,033
| +37% | +$791K | 0.01% | 506 |
|
|
2023
Q1 | $1.81M | Buy |
43,615
+15,361
| +54% | +$637K | 0.01% | 578 |
|
|
2022
Q4 | $1.25M | Buy |
28,254
+14,766
| +109% | +$655K | 0.01% | 660 |
|
|
2022
Q3 | $527K | Buy |
+13,488
| New | +$527K | ﹤0.01% | 808 |
|
|
2021
Q3 | – | Sell |
-6,426
| Closed | -$510K | – | 1030 |
|
|
2021
Q2 | $510K | Buy |
+6,426
| New | +$510K | ﹤0.01% | 785 |
|
|
2018
Q4 | – | Sell |
-6,000
| Closed | -$210K | – | 942 |
|
|
2018
Q3 | $210K | Buy |
+6,000
| New | +$210K | ﹤0.01% | 845 |
|